Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Roberts, Carly
DOB: 10-DEC-1969 (Age: 56)
Gender: female
Address:
2 Price meadow
LE4 Mitchellborough (United Kingdom)
ID: 9384-259853-9 (ECI)
Report
Date: 07-APR-2021
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
St Matthews Health & Community Centre
Malabar Road 62-66
LE1 4 Leicester (United Kingdom)
Specimen
Collected: 07-APR-2021

Chemistry

Test 07-APR-2021 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 129.5 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 132.4 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 71.3 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 31.7 L 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Lipid profile shows total cholesterol, triglycerides, and LDL within normal limits. However, HDL cholesterol is decreased, which may increase cardiovascular risk. Recommend lifestyle modifications (diet, exercise) to improve HDL and consider further cardiovascular risk assessment if clinically indicated. No other significant abnormalities detected.